» Articles » PMID: 22065011

P2Y Purinoceptors Induce Changes in Intracellular Calcium in Acinar Cells of Rat Lacrimal Glands

Overview
Publisher Springer
Date 2011 Nov 9
PMID 22065011
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine 5'-triphosphate (ATP) is an extracellular signal that regulates various cellular functions. Cellular secretory activities are enhanced by ATP as well as by cholinergic and adrenergic stimuli. The present study aimed to determine which purinoceptors play a role in ATP-induced changes in the intracellular concentration of calcium ions ([Ca²⁺](i)) and in the fine structure of acinar cells of rat lacrimal glands. ATP induced exocytotic structures, vacuolation and an increase in [Ca²⁺](i) in acinar cells. The removal of extracellular Ca²⁺ or the use of Ca²⁺ channel blockers partially inhibited the ATP-induced [Ca²⁺](i) increase. U73122 (an antagonist of PLC) and heparin (an antagonist of IP₃ receptors) did not completely inhibit the ATP-induced [Ca²⁺](i) increase. P1 purinoceptor agonists did not induce any changes in [Ca²⁺](i), whereas suramin (an antagonist of P2 receptors) completely inhibited ATP-induced changes in [Ca²⁺](i). A P2Y receptor agonist, 2-MeSATP, induced a strong increase in [Ca²⁺](i), although UTP (a P2Y₂,₄,₆ receptor agonist) had no effect, and reactive blue 2 (a P2Y receptor antagonist) resulted in partial inhibition. The potency order of ATP analogs (2-MeSATP > ATP >>> UTP) suggested that P2Y₁ played a significant role in the cellular response to ATP. BzATP (a P2X₇ receptor agonist) induced a small increase in [Ca²⁺](i), but α,β-meATP (a P2X₁,₃ receptor agonist) had no effect. RT-PCR indicated that P2X₂,₃,₄,₅,₆,₇ and P2Y₁,₂,₄,₁₂,₁₄ are expressed in acinar cells. In conclusion, the response of acinar cells to ATP is mediated by P2Y (especially P2Y₁) as well as by P2X purinoceptors.

Citing Articles

Novel Insights Into Muscarinic and Purinergic Responses in Primary Cultures of Rat Lacrimal Gland Myoepithelial Cells.

Dankis M, Carlsson T, Aronsson P, Tobin G, Winder M Invest Ophthalmol Vis Sci. 2021; 62(12):19.

PMID: 34546325 PMC: 8458779. DOI: 10.1167/iovs.62.12.19.


P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction.

Khalafalla M, Woods L, Jasmer K, Munoz Forti K, Camden J, Jensen J Front Pharmacol. 2020; 11:222.

PMID: 32231563 PMC: 7082426. DOI: 10.3389/fphar.2020.00222.


Signaling Pathways of Purinergic Receptors and Their Interactions with Cholinergic and Adrenergic Pathways in the Lacrimal Gland.

Hodges R, Dartt D J Ocul Pharmacol Ther. 2016; 32(8):490-497.

PMID: 27463365 PMC: 5069734. DOI: 10.1089/jop.2016.0008.


The Histochemistry and Cell Biology compendium: a review of 2012.

Taatjes D, Roth J Histochem Cell Biol. 2013; 139(6):815-46.

PMID: 23665922 DOI: 10.1007/s00418-013-1098-5.


Effects of protease-activated receptors (PARs) on intracellular calcium dynamics of acinar cells in rat lacrimal glands.

Oikawa M, Saino T, Kimura K, Kamada Y, Tamagawa Y, Kurosaka D Histochem Cell Biol. 2013; 140(4):463-76.

PMID: 23463389 DOI: 10.1007/s00418-013-1082-0.

References
1.
Matsuura M, Saino T, Satoh Y . Response to ATP is accompanied by a Ca2+ influx via P2X purinoceptors in the coronary arterioles of golden hamsters. Arch Histol Cytol. 2004; 67(1):95-105. DOI: 10.1679/aohc.67.95. View

2.
Fredholm B, Abbracchio M, Burnstock G, Dubyak G, Harden T, Jacobson K . Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci. 1997; 18(3):79-82. PMC: 4460977. DOI: 10.1016/s0165-6147(96)01038-3. View

3.
Fumagalli M, Trincavelli L, Lecca D, Martini C, Ciana P, Abbracchio M . Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor. Biochem Pharmacol. 2004; 68(1):113-24. DOI: 10.1016/j.bcp.2004.02.038. View

4.
Brian Doctor R, Matzakos T, McWilliams R, Johnson S, Feranchak A, Fitz J . Purinergic regulation of cholangiocyte secretion: identification of a novel role for P2X receptors. Am J Physiol Gastrointest Liver Physiol. 2004; 288(4):G779-86. DOI: 10.1152/ajpgi.00325.2004. View

5.
Ryan L, Rachow J, McCarty B, McCarty D . Adenosine triphosphate levels in human plasma. J Rheumatol. 1996; 23(2):214-9. View